Viewing Study NCT06057350


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-02 @ 2:04 AM
Study NCT ID: NCT06057350
Status: RECRUITING
Last Update Posted: 2024-02-16
First Post: 2023-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR
Sponsor: Norwegian Department of Health and Social Affairs
Organization:

Study Overview

Official Title: Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR (SCAR)- a Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCAR
Brief Summary: Randomized head-to-head comparison trial among patients who have undergone incomplete endoscopic resection of early colon cancer to evaluate the benefits, harms and burdens, as well as the ecological footprint and cost-effectiveness of endoscopic full thickness resection (eFTR), a minimally invasive endoscopic treatment with a colonoscope, as compared to standard-of-care surgery.

Co-primary endpoints are

* Rate of severe adverse events classified as grade III to V according to the Clavien Dindo classification within 30-days after study treatment
* CRC recurrence or sign of lymph nodes or distant metastases at 3 years after randomization comparing the two treatment groups (eFTR versus surgery).
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: